15hon MSN
Wegovy Pill Launch Promises Change — But Its Cost and What It Does Could Decide Who Gets Help
The Wegovy pill has been approved, but questions over cost and access could shape who benefits from the new oral weight-loss ...
Key market opportunities for liraglutide and semaglutide include their growing role in diabetes and obesity treatment due to ...
SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / December 23, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing CID-103, a potential ...
Sintana Energy Inc. (TSX-V: SEI, AIM: SEI, OTCQX: SEUSF) (“Sintana” or the “Company”) is pleased to announce the admission of its common shares ...
Investing.com -- Novo Nordisk’s (CSE:NOVOb) long-awaited entry into the obesity pill market lifted investor sentiment, with ...
Despite the initial optimism, BMO urged caution, emphasizing that the advantage may be short-lived. The firm said Eli Lilly’s oral GLP-1 candidate, orforglipron, is still expected to receive approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback